Differences and similarities between IgG4-related disease with and without dacryoadenitis and sialoadenitis: clinical manifestations and treatment efficacy

Arthritis Res Ther. 2019 Feb 1;21(1):44. doi: 10.1186/s13075-019-1828-8.

Abstract

Background: This study aimed to compare the differences and similarities in the clinical manifestations and treatment efficacy of IgG4-related disease (IgG4-RD) in patients with and without dacryoadenitis and sialoadenitis (DS).

Methods: A total of 121 untreated IgG4-RD patients in Peking Union Medical College Hospital were enrolled in this study. The patients were divided into three groups: DS-predominant (group A), non-DS (group B), and DS with other internal organs affected (group C). The patients were followed up for at least 15 months. Baseline and follow-up data were collected. The disease activity was evaluated according to the IgG4-RD responder index.

Results: The mean ± SD age at disease onset was 53.2 ± 14.1 years, and 71.9% of the patients were male. The prevalence of allergies was higher in groups A (21, 61.8%) and C (32, 69.6%) than group B (14, 34.1%). More patients with DS (17, 50.0%, and 17, 37.0%) had sinonasal lesions than those without DS (5, 12.2%). Moreover, an increased number of eosinophils were more common in patients with DS than in those without, as were increased serum IgG, IgG4, and IgE levels. More patients in group B and group C (28, 68.3%, and 31, 67.4%) received a combination therapy of corticosteroid and immunosuppressant. During the 15-month follow-up, 28 (23.1%) patients had disease relapse.

Conclusion: Results demonstrated that IgG4-RD patients with DS had distinctive clinical features compared with non-DS. Allergy and sinonasal involvement were more common in patients with DS. Patients with DS showed higher serum IgG4 levels than those without DS.

Keywords: Dacryoadenitis; IgG4-RD; IgG4-RD RI; Sialoadenitis; Treatment.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Dacryocystitis / blood
  • Dacryocystitis / complications
  • Dacryocystitis / drug therapy*
  • Drug Therapy, Combination
  • Eosinophils / metabolism
  • Female
  • Glucocorticoids / therapeutic use*
  • Humans
  • Immunoglobulin E / blood
  • Immunoglobulin G / blood
  • Immunoglobulin G4-Related Disease / blood
  • Immunoglobulin G4-Related Disease / complications
  • Immunoglobulin G4-Related Disease / drug therapy*
  • Immunosuppressive Agents / therapeutic use*
  • Male
  • Middle Aged
  • Sialadenitis / blood
  • Sialadenitis / complications
  • Sialadenitis / drug therapy*
  • Treatment Outcome

Substances

  • Glucocorticoids
  • Immunoglobulin G
  • Immunosuppressive Agents
  • Immunoglobulin E